NL-OMON34333已完成4 期
ong term prospective follow-up study of tocilizumab (RoActermraR) administered to patients with rheumatoid arthritis in daily clinical practice. - tocilizumab in rheumatoid arthritis
Jan van Breemen Instituut0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •rheumatoid arthritis and treatment with tocilizumab
排除标准
- •contraindications for treatment with tocilizumab
- •No signed informed consent
研究者
相似试验
已完成
不适用
Clinical trial of long term efficacy for tocilizumab in systemic sclerosis and sclerodermatous chronic GVHDThe patients with systemic sclerosis or sclerodermatous chronic GVHD.JPRN-UMIN000022624Kanazawa University Hospital5
已完成
4 期
A study for effectiveness and safety of tocilizumab therapy in rheumatoid arthritis patients with renal insufficiency.Rheumatoid arthritisJPRN-UMIN000014934HO Kumamoto Saishunsou National Hospital400
已完成
不适用
Tocilizumab long-term extension trial in patients with adult onset stillAdult onset still diseaseJPRN-UMIN000018414Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine34
招募中
不适用
ong term follow-up observational study after clinical trials of AMG531 (Romiplostim) in patients with untreated Aplastic Anemia (531-005 Study)aplastic anemiaJPRN-UMIN000044014Kyowa Kirin Co., Ltd.45
招募中
3 期
Tocilizumab in severe COVID-19COVID-19.COVID-19U07.1IRCT20150303021315N17Aryogen Pharmed85